U.S. stocks wavered Tuesday as America headed to the polls in a closely-watched presidential election between Hillary Clinton and Donald Trump. Stocks are on hold after a significant rally on Monday, where equities posted their largest gains since March 1 and snapped a nine session losing streak. "Whoever ends up in residence at 1600 Pennsylvania Avenue is going to have a pretty disgruntled electorate to try to bring along and I think markets will react to some of that," said Carol Schleif, deputy chief investment officer at Abbot Downing. Meanwhile, shares of Valeant Pharmaceuticals (VRX) slumped after reporting a disappointing outlook. The troubled pharmaceuticals giant is forecasting full-year earnings of between $5.30 and $5.50 a share, compared to previous estimate of $6.60 to $7 a share. Results for its most recent quarter also came in below forecasts and revenue fell 11% year-over-year. CVS Health (CVS) shares fell after reporting lower full-year earnings guidance. The company exceeded Wall Street's third quarter earnings estimates, but missed on the top line. TheStreet's Scott Gamm reports from Wall Street.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.